Skip to main content
. 2019 Mar;48(3):531–540.

Table 3:

Allele and genotype distribution of various SNPs of ERAP1, 2 in preeclampsia cases and healthy controls

dbSNP Alleles/Genotypes Case (n=148) N (%) Control (n=133) N (%) P value OR (95% CI)
rs28096 A 110 (37.4) 105 (39.5) 0.61 0.91 (0.65–1.28)
G 184 (62.16) 161 (60.5) 0.61 1.09 (0.77–1.53)
AA 19 (12.9) 20 (15.0) 0.61 0.83 (0.42–1.65)
AG 72 (49.0) 65 (48.9) 0.98 1.00 (0.62–1.60)
GG 56 (38.1) 48 (36.1) 0.72 1.08 (0.67–1.77)
HWE 0.798
rs30187 T 129 (43.6) 102 (38.9) 0.26 1.21 (0.86–1.69)
C 167 (56.4) 160 (61.1) 0.26 0.82 (0.58–1.15)
TT 28 (18.9) 18 (13.7) 0.24 1.46 (0.76–2.79)
TC 73 (49.3) 66 (50.4) 0.86 0.95 (0.59–1.53)
CC 47 (31.8) 47 (35.9) 0.46 0.83 (0.50–1.36)
HWE 0.498
rs26653 C 122 (41.5) 112 (42.1) 0.88 0.97 (0.69–1.36)
G 172 (58.5) 154 (57.9) 0.88 1.02 (0.73–1.43)
CC 27 (18.4) 25 (18.8) 0.92 0.97 (0.53–1.77)
CG 68 (46.3) 62 (46.6) 0.95 0.98 (0.61–1.57)
GG 52 (35.4) 46 (34.6) 0.89 1.03 (0.63–1.69)
HWE 0.618
rs3734016 A 293 (99.0) 266 (100) 0.099 -
G 3 (1) 0 (0) 0.099 -
AA 145 (98.0) 133 (100) 0.099 -
AG 3 (2) 0 (0) 0.099 -
GG 0 (.0) 0 (0) - -
HWE 1.00
rs34750 C 174 (59.18) 155 (58.27) 0.82 1.03 (0.74–1.45)
G 120 (40.82) 111 (41.73) 0.82 0.96 (0.68–1.34)
CC 54 (36.73) 47 (35.34) 0.80 1.06 (0.65–1.73)
CG 66 (44.90) 61 (45.86) 0.87 0.96 (0.60–1.54)
GG 27 (18.37) 25 (18.80) 0.21 0.97 (0.53–1.77)
HWE 0.51
rs2549782 T 121 (40.88) 107 (40.23) 0.87 1.02 (0.73–1.43)
G 175 (59.12) 159 (59.77) 0.87 0.97 (0.69–1.36)
TT 51 (34.5) 43 (32.3) 0.70 1.10 (0.66–1.80)
TG 73 (49.3) 73 (54.9) 0.35 0.80 (0.50–1.27)
GG 24 (16.2) 17 (12.8) 0.41 1.32 (0.67–2.58)
HWE 0.10
rs17408150 A 25 (8.4) 34 (12.8) 0.094 0.62 (0.36–1.08)
T 271 (91.6) 232 (87.2) 0.094 1.58 (0.92–2.74)
AA 0 (0) 3 (2.3) 0.066 -
AT 25 (16.9) 28(21.1) 0.37 0.76 (0.41–1.38)
TT 123 (83.1) 102(76.7) 0.17 1.49 (0.83–2.69)
HWE 0.52

OR, odds ratio; CI, confidence interval; - means Not Calculated